Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2025

Dec. 31, 2024

Cara Therapeutics, Inc.

Summary of Changes in accumulated other comprehensive loss, net of tax, from unrealized gains on available-for-sale marketable securities

	Total Accumulated
	Other Comprehensive
	Loss
Balance, December 31, 2024	$	—
Other comprehensive income before reclassifications		—
Amount reclassified from accumulated other comprehensive loss		—
Net current period other comprehensive income		—
Balance, March 31, 2025	$	—
Balance, December 31, 2023	$	(260)
Other comprehensive income before reclassifications		69
Amount reclassified from accumulated other comprehensive loss		—
Net current period other comprehensive income		69
Balance, March 31, 2024	$	(191)

	Total Accumulated
	Other Comprehensive
	Income (Loss)
Balance, December 31, 2021	$	(358)
Other comprehensive loss before reclassifications		(1,314)
Amount reclassified from accumulated other comprehensive loss		—
Net current period other comprehensive loss		(1,314)
Balance, December 31, 2022		(1,672)
Other comprehensive income before reclassifications		1,412
Amount reclassified from accumulated other comprehensive loss		—
Net current period other comprehensive income		1,412
Balance, December 31, 2023	$	(260)
Other comprehensive income before reclassifications		260
Amount reclassified from accumulated other comprehensive loss		—
Net current period other comprehensive income		260
Balance, December 31, 2024	$	—